ATE307339T1 - Verwendung des vaskularen endothelialen wachstumsfaktors (vegf) - Google Patents

Verwendung des vaskularen endothelialen wachstumsfaktors (vegf)

Info

Publication number
ATE307339T1
ATE307339T1 AT99959565T AT99959565T ATE307339T1 AT E307339 T1 ATE307339 T1 AT E307339T1 AT 99959565 T AT99959565 T AT 99959565T AT 99959565 T AT99959565 T AT 99959565T AT E307339 T1 ATE307339 T1 AT E307339T1
Authority
AT
Austria
Prior art keywords
vegf
growth factor
vascular endothelial
endothelial growth
phosphorylation
Prior art date
Application number
AT99959565T
Other languages
English (en)
Inventor
James Martin Staddon
Mary Louise Morgan
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9827407.9A external-priority patent/GB9827407D0/en
Priority claimed from GBGB9908061.6A external-priority patent/GB9908061D0/en
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE307339T1 publication Critical patent/ATE307339T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT99959565T 1998-12-11 1999-12-10 Verwendung des vaskularen endothelialen wachstumsfaktors (vegf) ATE307339T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9827407.9A GB9827407D0 (en) 1998-12-11 1998-12-11 Methods
GBGB9908061.6A GB9908061D0 (en) 1999-04-08 1999-04-08 Methods
PCT/GB1999/004162 WO2000036421A1 (en) 1998-12-11 1999-12-10 Use of vascular endothelial growth factor (vegf)

Publications (1)

Publication Number Publication Date
ATE307339T1 true ATE307339T1 (de) 2005-11-15

Family

ID=26314824

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99959565T ATE307339T1 (de) 1998-12-11 1999-12-10 Verwendung des vaskularen endothelialen wachstumsfaktors (vegf)

Country Status (6)

Country Link
US (3) US20020037544A1 (de)
EP (1) EP1137946B1 (de)
JP (1) JP2002532720A (de)
AT (1) ATE307339T1 (de)
DE (1) DE69927845D1 (de)
WO (1) WO2000036421A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI428143B (zh) * 2006-01-18 2014-03-01 Gen Hospital Corp 增加淋巴功能之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155031A (en) * 1990-06-07 1992-10-13 Posner Barry I Use of pervanadate as an inhibitor of phosphotyrosine phosphatase
GB9323884D0 (en) * 1993-11-19 1994-01-05 Eisai London Res Lab Ltd Physiological modulation
GB9423372D0 (en) * 1994-11-18 1995-01-11 Eisai London Res Lab Ltd Proteins and their uses
GB9620390D0 (en) * 1996-09-30 1996-11-13 Eisai London Res Lab Ltd Substances and their uses

Also Published As

Publication number Publication date
WO2000036421A8 (en) 2000-12-21
JP2002532720A (ja) 2002-10-02
WO2000036421A1 (en) 2000-06-22
EP1137946B1 (de) 2005-10-19
DE69927845D1 (de) 2005-11-24
EP1137946A1 (de) 2001-10-04
US20030129662A1 (en) 2003-07-10
US20020037544A1 (en) 2002-03-28
US20030134334A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
DE60141950D1 (de) Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
LTPA2014028I1 (lt) Pakeistieji 3-cianochinolinai kaip proteintirozinkinazės inhibitoriai
ATE115994T1 (de) Quasi-azeotrope mischungen zur verwendung als kältemittel.
DK162217C (da) Chlorquinolinderivater, herbicid indeholdende disse chlorquinolinderivater og fremgangsmaade til bekaempelse af uoensket plantevaekst med dette herbicid
ATE255575T1 (de) Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
DK0526488T3 (da) Benzylphosphonsyre-tyrosinkinaseinhibitorer
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
TR199900781T2 (xx) H�cre yap��ma inhibit�rleri
EA199900381A1 (ru) Арил(тио)эфиры галогенпиримидина в качестве пестицидов
CA2382199A1 (en) Hematology control and system for multi-parameter hematology measurements
EA200100208A1 (ru) Новая форма соли пантопразола
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
DE69431201D1 (de) Verwendung von indolderivaten als 5ht1-agonisten
PT1276763E (pt) Proteinas anti-congelantes sua producao e utilizacao
DE60107718T8 (de) Konservierung von zellen
WO2003021265A8 (en) Genetic construct intracellular monitoring system
DE69927845D1 (de) Verwendung des vaskularen endothelialen wachstumsfaktors (vegf)
DK1064018T3 (da) Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktioner
EA200100051A1 (ru) Ингибиторы fkbp
EA200200798A1 (ru) Кальцилитические соединения
TR200100013T2 (tr) N-tert-butilhidroksilaminin yeni tuzları.
TR200003713T2 (tr) Homosistein ve C-reaktif proteinin seviyelerinin düşürülmesi.
DE50106936D1 (de) Lösung zur Konservierung menschlicher Leberzellen, konservierte Leberzelle, und ihre Verwendung
ATE256661T1 (de) Bispiperidine mit antithrombotischer wirkung
DE68903268D1 (de) Verwendung von folinsaeurederivaten als plaettchenaggregationshemmstoffe.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties